HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

alpha-Bungarotoxin displacing antibody in myasthenia gravis.

Abstract
The majority of sera from myasthenic patients cannot precipitate all available receptor-toxin complex even in conditions of a 4,000-fold excess of antibody. This effect was traced to displacement of toxin from the receptor-toxin complex. Pure IgG prepared from the serum of a myasthenic patient was as effective as the original serum in displacing ability. The possible effect of such antibodies on the correlation of antibody titre and disease state is discussed.
AuthorsT Barkas, J A Simpson
JournalJournal of clinical & laboratory immunology (J Clin Lab Immunol) Vol. 9 Issue 2 Pg. 113-7 (Nov 1982) ISSN: 0141-2760 [Print] Scotland
PMID7154056 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Bungarotoxins
  • Immunoglobulin G
  • Receptors, Cholinergic
  • Receptors, Nicotinic
Topics
  • Antibody Specificity
  • Autoantibodies (immunology)
  • Binding, Competitive
  • Bungarotoxins (metabolism)
  • Humans
  • Immunoglobulin G (immunology)
  • Myasthenia Gravis (immunology)
  • Receptors, Cholinergic (immunology)
  • Receptors, Nicotinic (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: